Log In
BCIQ
Print this Print this
 

EDP-494

  Manage Alerts
Collapse Summary General Information
Company Enanta Pharmaceuticals Inc.
DescriptionCyclophilin inhibitor
Molecular Target Cyclophilin
Mechanism of ActionCyclophilin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotypes 1 and 3 infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today